The U.S. could authorize the firing of Pfizer COVID-19 for children ages 5 to 11 in October, according to sources
The anti-arthritis drug Sobi reduces the risk of death; heart medications can help prevent COVID-19 blood clots
/cloudfront-us-east-2.images.arcpublishing.com/reuters/WZT3C5BDKRM7VBXUNNEG27LKHA.jpg "An Indian study found a large drop in COVID antibodies in the four months following vaccination")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LOOZGBF6XRKNNIRTMNXOOHI3GM.jpg "England will offer the COVID vaccine to all young people aged 12 to 15")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BD5K2CF4GRPRHETPBE3BAELBIU.jpg "COVID-19 vaccine boosters are not much needed, according to leading FDA and WHO scientists")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PE5M37V6IBJITAUYLO3QKL4XMU.jpg "New Zealand buys 500,000 COVID-19 vaccines as the cluster grows")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/JHQ5KDUZBBMQPFYHJM7VZ2EEME.jpg "British Prime Minister Johnson will address parliament for COVID-19, according to a BBC reporter")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/GGF544HPPRK2VLHWSNEWYFYVKQ.jpg "The U.S. could authorize the firing of Pfizer COVID-19 for children ages 5 to 11 in October, according to sources")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LGDRTWA5SBP2VGI7T7DSJDCVD4.jpg "Novavax expects to make at least 2 trillion doses of COVID-19 vaccine available in 2022")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ASAZC3JCXRPIFPVR2YH36VZQQI.jpg "COVID-19 vaccines remain strong against Delta, decreasing protection in older adults")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/TFGFSYGFFZJ35PNIXIZ7OEMJZE.jpg "The anti-arthritis drug Sobi reduces the risk of death; heart medications can help prevent COVID-19 blood clots")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XA3ISOF3EROIZE3YJWGU3K4IF4.jpg "BioNTech will soon apply for the vaccine for children ages 5-11-Spiegel")